CRISPR Gene Editing Market Size, Share & Trends

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global CRISPR Gene Editing Market Size Analysis

Global CRISPR Gene Editing Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. CRISPR Products
  1. By Value
  2. Kits and Enzymes
    1. Kits and Enzymes By Value
  3. Libraries
    1. Libraries By Value
  4. Design Tools, Antibodies
    1. Design Tools, Antibodies By Value
  5. Others
    1. Others By Value
3. CRISPR Services
  1. By Value
  2. gRNA Design and Vector Construction
    1. gRNA Design and Vector Construction By Value
  3. Cell Line and Engineering
    1. Cell Line and Engineering By Value
  4. Screening Services
    1. Screening Services By Value
  5. Others
    1. Others By Value
By Application
1. Introduction
  1. Application By Value
2. Agricultural
  1. By Value
3. Biomedical
  1. By Value
4. Industrial
  1. By Value
5. Genome Engineering
  1. By Value
6. Disease Models
  1. By Value
7. Functional Genomics
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic Institutes and Research Centres
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Pharmaceutical and Biopharmaceutical Companies
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. CRISPR Products
  1. By Value
  2. Kits and Enzymes
    1. Kits and Enzymes By Value
  3. Libraries
    1. Libraries By Value
  4. Design Tools, Antibodies
    1. Design Tools, Antibodies By Value
  5. Others
    1. Others By Value
3. CRISPR Services
  1. By Value
  2. gRNA Design and Vector Construction
    1. gRNA Design and Vector Construction By Value
  3. Cell Line and Engineering
    1. Cell Line and Engineering By Value
  4. Screening Services
    1. Screening Services By Value
  5. Others
    1. Others By Value
By Application
1. Introduction
  1. Application By Value
2. Agricultural
  1. By Value
3. Biomedical
  1. By Value
4. Industrial
  1. By Value
5. Genome Engineering
  1. By Value
6. Disease Models
  1. By Value
7. Functional Genomics
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic Institutes and Research Centres
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. CRISPR Products
    1. By Value
    2. Kits and Enzymes
      1. Kits and Enzymes By Value
    3. Libraries
      1. Libraries By Value
    4. Design Tools, Antibodies
      1. Design Tools, Antibodies By Value
    5. Others
      1. Others By Value
  3. CRISPR Services
    1. By Value
    2. gRNA Design and Vector Construction
      1. gRNA Design and Vector Construction By Value
    3. Cell Line and Engineering
      1. Cell Line and Engineering By Value
    4. Screening Services
      1. Screening Services By Value
    5. Others
      1. Others By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Agricultural
    1. By Value
  3. Biomedical
    1. By Value
  4. Industrial
    1. By Value
  5. Genome Engineering
    1. By Value
  6. Disease Models
    1. By Value
  7. Functional Genomics
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Academic Institutes and Research Centres
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. CRISPR Products
  1. By Value
  2. Kits and Enzymes
    1. Kits and Enzymes By Value
  3. Libraries
    1. Libraries By Value
  4. Design Tools, Antibodies
    1. Design Tools, Antibodies By Value
  5. Others
    1. Others By Value
3. CRISPR Services
  1. By Value
  2. gRNA Design and Vector Construction
    1. gRNA Design and Vector Construction By Value
  3. Cell Line and Engineering
    1. Cell Line and Engineering By Value
  4. Screening Services
    1. Screening Services By Value
  5. Others
    1. Others By Value
By Application
1. Introduction
  1. Application By Value
2. Agricultural
  1. By Value
3. Biomedical
  1. By Value
4. Industrial
  1. By Value
5. Genome Engineering
  1. By Value
6. Disease Models
  1. By Value
7. Functional Genomics
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic Institutes and Research Centres
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. CRISPR Products
    1. By Value
    2. Kits and Enzymes
      1. Kits and Enzymes By Value
    3. Libraries
      1. Libraries By Value
    4. Design Tools, Antibodies
      1. Design Tools, Antibodies By Value
    5. Others
      1. Others By Value
  3. CRISPR Services
    1. By Value
    2. gRNA Design and Vector Construction
      1. gRNA Design and Vector Construction By Value
    3. Cell Line and Engineering
      1. Cell Line and Engineering By Value
    4. Screening Services
      1. Screening Services By Value
    5. Others
      1. Others By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Agricultural
    1. By Value
  3. Biomedical
    1. By Value
  4. Industrial
    1. By Value
  5. Genome Engineering
    1. By Value
  6. Disease Models
    1. By Value
  7. Functional Genomics
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Academic Institutes and Research Centres
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. CRISPR Products
  1. By Value
  2. Kits and Enzymes
    1. Kits and Enzymes By Value
  3. Libraries
    1. Libraries By Value
  4. Design Tools, Antibodies
    1. Design Tools, Antibodies By Value
  5. Others
    1. Others By Value
3. CRISPR Services
  1. By Value
  2. gRNA Design and Vector Construction
    1. gRNA Design and Vector Construction By Value
  3. Cell Line and Engineering
    1. Cell Line and Engineering By Value
  4. Screening Services
    1. Screening Services By Value
  5. Others
    1. Others By Value
By Application
1. Introduction
  1. Application By Value
2. Agricultural
  1. By Value
3. Biomedical
  1. By Value
4. Industrial
  1. By Value
5. Genome Engineering
  1. By Value
6. Disease Models
  1. By Value
7. Functional Genomics
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic Institutes and Research Centres
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. CRISPR Products
    1. By Value
    2. Kits and Enzymes
      1. Kits and Enzymes By Value
    3. Libraries
      1. Libraries By Value
    4. Design Tools, Antibodies
      1. Design Tools, Antibodies By Value
    5. Others
      1. Others By Value
  3. CRISPR Services
    1. By Value
    2. gRNA Design and Vector Construction
      1. gRNA Design and Vector Construction By Value
    3. Cell Line and Engineering
      1. Cell Line and Engineering By Value
    4. Screening Services
      1. Screening Services By Value
    5. Others
      1. Others By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Agricultural
    1. By Value
  3. Biomedical
    1. By Value
  4. Industrial
    1. By Value
  5. Genome Engineering
    1. By Value
  6. Disease Models
    1. By Value
  7. Functional Genomics
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Academic Institutes and Research Centres
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. CRISPR Products
  1. By Value
  2. Kits and Enzymes
    1. Kits and Enzymes By Value
  3. Libraries
    1. Libraries By Value
  4. Design Tools, Antibodies
    1. Design Tools, Antibodies By Value
  5. Others
    1. Others By Value
3. CRISPR Services
  1. By Value
  2. gRNA Design and Vector Construction
    1. gRNA Design and Vector Construction By Value
  3. Cell Line and Engineering
    1. Cell Line and Engineering By Value
  4. Screening Services
    1. Screening Services By Value
  5. Others
    1. Others By Value
By Application
1. Introduction
  1. Application By Value
2. Agricultural
  1. By Value
3. Biomedical
  1. By Value
4. Industrial
  1. By Value
5. Genome Engineering
  1. By Value
6. Disease Models
  1. By Value
7. Functional Genomics
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic Institutes and Research Centres
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. CRISPR Products
    1. By Value
    2. Kits and Enzymes
      1. Kits and Enzymes By Value
    3. Libraries
      1. Libraries By Value
    4. Design Tools, Antibodies
      1. Design Tools, Antibodies By Value
    5. Others
      1. Others By Value
  3. CRISPR Services
    1. By Value
    2. gRNA Design and Vector Construction
      1. gRNA Design and Vector Construction By Value
    3. Cell Line and Engineering
      1. Cell Line and Engineering By Value
    4. Screening Services
      1. Screening Services By Value
    5. Others
      1. Others By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Agricultural
    1. By Value
  3. Biomedical
    1. By Value
  4. Industrial
    1. By Value
  5. Genome Engineering
    1. By Value
  6. Disease Models
    1. By Value
  7. Functional Genomics
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Academic Institutes and Research Centres
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. CRISPR Products
  1. By Value
  2. Kits and Enzymes
    1. Kits and Enzymes By Value
  3. Libraries
    1. Libraries By Value
  4. Design Tools, Antibodies
    1. Design Tools, Antibodies By Value
  5. Others
    1. Others By Value
3. CRISPR Services
  1. By Value
  2. gRNA Design and Vector Construction
    1. gRNA Design and Vector Construction By Value
  3. Cell Line and Engineering
    1. Cell Line and Engineering By Value
  4. Screening Services
    1. Screening Services By Value
  5. Others
    1. Others By Value
By Application
1. Introduction
  1. Application By Value
2. Agricultural
  1. By Value
3. Biomedical
  1. By Value
4. Industrial
  1. By Value
5. Genome Engineering
  1. By Value
6. Disease Models
  1. By Value
7. Functional Genomics
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic Institutes and Research Centres
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. CRISPR Products
    1. By Value
    2. Kits and Enzymes
      1. Kits and Enzymes By Value
    3. Libraries
      1. Libraries By Value
    4. Design Tools, Antibodies
      1. Design Tools, Antibodies By Value
    5. Others
      1. Others By Value
  3. CRISPR Services
    1. By Value
    2. gRNA Design and Vector Construction
      1. gRNA Design and Vector Construction By Value
    3. Cell Line and Engineering
      1. Cell Line and Engineering By Value
    4. Screening Services
      1. Screening Services By Value
    5. Others
      1. Others By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Agricultural
    1. By Value
  3. Biomedical
    1. By Value
  4. Industrial
    1. By Value
  5. Genome Engineering
    1. By Value
  6. Disease Models
    1. By Value
  7. Functional Genomics
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Academic Institutes and Research Centres
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

CRISPR Gene Editing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

CRISPR Therapeutics AG
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Thermo Fisher Scientific, Inc.
Synthego Corporation
System Biosciences LLC
ToolGen, Inc.
Agilent Technologies, Inc.
Rockland Immunochemicals, Inc.
GeneCopoeia, Inc.
Horizon Discovery Group PLC
Abcam, Inc.
Applied StemCell, Inc.
Cellecta, Inc.
Integrated DNA Technologies, Inc.
Merck KGaA
New England Biolabs, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment